Fluconazole and amphotericin-B resistance are associated with increased catalase and superoxide dismutase activity in Candida albicans and Candida dubliniensis

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 46, Issue 6, 2013, Pages 752-758

  Linares, Carlos Eduardo Blanco ^a   Giacomelli, Sandro Rogério ^b   Altenhofen, Delsi ^b   Alves, Sydney Hartz ^c   Morsch, Vera Maria ^c   Schetinger, Maria Rosa Chitolina ^c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Universidade Regional Integrada do Alto Uruguai   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Candida albicans; Candida dubliniensis; Catalase; Superoxide dismutase

Indexed keywords

AMPHOTERICIN B; CATALASE; FLUCONAZOLE; SUPEROXIDE DISMUTASE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; ENZYME ACTIVITY; FUNGAL STRAIN; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; ULTRAVIOLET SPECTROPHOTOMETRY;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDA ALBICANS; CATALASE; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; MICROBIAL SENSITIVITY TESTS; SUPEROXIDE DISMUTASE;

EID: 84892755030     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/0037-8682-0190-2013     Document Type: Article

References (35)

1. Fotedar R, Al-Hedaithy SS. Candida dubliniensis at a University in Saudi Arabia. J Clin Microbiol 2003; 41:1907-1911.
2. Odds FC, Nuffel LV, Dams G. Prevalence of Candida dubliniensis isolates in a yeast stock collection. J Clin Microbiol 1998; 36:2869-2973.
3. Polacheck I, Strahilevitz J, Sullivan D, Donnelly S, Salkin IF, Coleman DC. Recovery of Candida dublinensis from non-human immunodeficiency virus-infected patients in Israel. J Clin Microbiol 2000; 38:170-174.
4. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995; 141:1507-1521.
5. Nunn MA, Schäfer SM, Petrou MA, Brown RM. Environmental source of Candida dubliniensis. Emerg Infect Dis 2007; 13:747-750.
6. Loreto ES, Scheid LA, Nogueira CW, Zeni G, Santurio JM, Alves SH. Candida dubliniensis: epidemiology and phenotypic methods for identification. Mycopathologia 2010; 169:431-443.
7. Moran GP, Sullivan DJ, Henman MC, McCreary CE, Harrington BJ, Shanley DB, et al. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazoleresistant derivatives in vitro. Antimicrob Agents Chemother 1997; 41: 617-623.
8. Bodey GP. Azole antifungal agents. Clin Infect Dis 1992; 14: 161-169.
9. Thomas AH. Suggested mechanisms for the antimycotic activity for the polyene antibiotics and the N-substituted imidazoles. J Antimicrob Chemother 1986; 17:269-279.
10. Vázquez N, Walsh TJ, Friedman D, Chanock SJ, Lyman CA Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans. Infect Immun 1998; 66:145-150.
11. Johnson F, Giulivi C. Superoxide dismutases and their impact upon human health. Mol Aspects Med 2005; 26:340-352.
12. Martchenko M, Alarco A, Harcus D, Whiteway M. Superoxide Dismutases in Candida albicans: Transcriptional Regulation and Functional Characterization of the Hyphal-induced SOD5 Gene. Mol Biol Cell 2004; 15:456-467.
13. Sokol-Anderson M, Sligh JE, Jr Elberg S, Brajtburg J, Kobayashi GS, Medoff G. Role of cell defense against oxidative damage in the resistance of Candida albicans to the killing effect of amphotericin B. Antimicrob Agents Chemother 1998; 32:702-705.
14. Nakagawa Y, Kanbe T, Mizuguchi I. Disruption of the human pathogenic yeast Candida albicans catalase gene decreased survival in mousemodel infection and elevated susceptibility to higher temperature and to detergents. Microbiol Immunol 2003; 47:395-403.
15. Sokol-Anderson ML, Brajtburg J, Medoff G. Amphotericin B-induced oxidative damage and killing of Candida albicans. J Infect Dis 1986; 154:76-83.
16. Michiels C, Raes M, Toussaint O, Remacle J. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med 1994; 17:235-248.
17. Lortz S, Tiedge M. Sequential inactivation of reactive oxygen species by combined overexpression of SOD isoforms and catalase in insulinproducing cells. Free Radic Biol Med 2003; 34:683-688.
18. Bauer D, Muller H, Reich J, Riedel H, Ahrenkeil V, Warthoe P, et al. Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR). Nuc Acids Res 1993; 21:4272-4280.
19. Clinical and Laboratory Standards Institute (CLSI). (2008) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard, M27-A3. Wayne, PA: Clinical and Laboratory Standards Institute.
20. Fekete-Forgács K, Gyüre L, Lenkey B. Changes of virulence factors accompanying the phenomenon of induced fluconazole resistance in Candida albicans. Mycoses 2000; 43:273-279.
21. McCord JM, Fridovich I. Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244:6049-6055.
22. Aebi H. Catalase in vitro. Method Enzymol 1984; 105: 121-126.
23. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
24. De Bernardis F, Sullivan PA, Cassone A. Aspartyl proteinases of Candida albicans and their role in pathogenicity. Med Mycol 2001; 39:303-313.
25. Linares CEB, Loreto ES, Silveira CP, Pozzatti P, Scheid LA, Santurio JM, et al. Enzymatic and hemolytic activities of Candida dubliniensis strains. Rev Inst Med Trop S Paulo 2007; 49:203-206.
26. Kothavade RJ, Panthaki MH. Evaluation of phospholipase activity of Candida albicans and its correlation with pathogenicity in mice. J Med Microbiol 1998; 47:99-102.
27. Lee J, Godon, C, Lagniel G, Specto D, Garini J, Labarre J, et al. Yap1 and Skn7 Control Two Specialized Oxidative Stress Response Regulons in Yeast. J Biol Chem 1999; 274:16040-16046.
28. Nakagawa Y. Catalase gene disruptant of the human pathogenic yeast Candida albicans is defective in hyphal growth, and a catalase-specific inhibitor can suppress hyphal growth of wild-type cells. Microbiol Immunol 2008; 52:16-24.
29. Giro M, Carrillo N, Krapp AR. Glucose-6-phosphate dehydrogenase and ferredoxin-NADP(H) reductase contribute to damage repair during the soxRS response of Escherichia coli. Microbiol 2006; 152:1119-1128.
30. Ikner A, Shizaki K. Yeast signalling pathways in the oxidative stress response. Mut Res 2005; 569:13-17.
31. Jamieson DJ. Saccharomyces cerevisiae has distinct adaptive responses to both hydrogen peroxide and menadione. J Bacteriol 1992; 174: 6678-6681.
32. Turton HE, Dawes IW, Grant CM. Saccharomyces cerevisiae exhibits a yAP-1-mediated adaptive response to malondialdehyde. J Bacteriol 1997; 179:1096-1101.
33. Enjalbert B, Moran GP, Vaughan C, Yeomans T, Maccallum DM, Quinn J, et al. Genome-wide gene expression profiling and a forward genetic screen show that differential expression of the sodium ion transporter Ena21 contributes to the differential tolerance of Candida albicans and Candida dubliniensis to osmotic stress. Mol Microbiol 2009; 72:216-228.
34. Moran GP, MacCallum DM, Spiering MJ, Coleman DC, Sullivan DJ. Differential regulation of the transcriptional repressor NRG1 accounts for altered host-cell interactions in Candida albicans and Candida dubliniensis. Mol Microbiol 2007; 66:915-929.
35. O'Connor L, Caplice N, Coleman DC, Sullivan DJ, Moran GP. Differential filamentation of Candida albicans and Candida dubliniensis is governed by nutrient regulation of UME6 expression. Eukaryot Cell 2010; 9: 1383-1397.